Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
236,833,431
-
Total 13F shares
-
8,453,450
-
Share change
-
-457,610
-
Total reported value
-
$26,039,000
-
Price per share
-
$3.08
-
Number of holders
-
17
-
Value change
-
-$2,115,756
-
Number of buys
-
7
-
Number of sells
-
7
Institutional Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q3 2017
As of 30 Sep 2017,
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,453,450 shares.
The largest 10 holders included
Aisling Capital LLC, Biomark Capital Management Co. LLC, Consonance Capital Management LP, PERCEPTIVE ADVISORS LLC, Iguana Healthcare Management, LLC, FMR LLC, VANGUARD GROUP INC, PRELUDE CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Bank of New York Mellon Corp.
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.